Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Trinity Hunt Partners Announces Majority Investment in Centricity Research
Trinity Hunt Partners announced on May 31 a majority investment in Centricity Research, a leading clinical research services provider specializing in conducting Phase I-IV clinical trials across more than 40 therapeutic areas. With more than 35 locations across the United States and Canada, Centricity has the capabilities and expertise to partner with pharmaceutical sponsors and contract research organizations in the design and execution of clinical trials. The company’s centralized processes, patient recruitment capabilities, integrated technology and dedicated team of clinical research professionals have conducted more than 2,500 studies and more than 100 FDA and Health Canada drug... Read More »
RC Capital Acquires James River Cardiology
Cincinnati-based private equity firm, RC Capital, announced on May 31 that it acquired James River Cardiology. By partnering with James River Cardiology, RC Capital formed Aligned Cardiovascular Partners. Provident Healthcare Partners advised James River Cardiology and Kaufman & Canoles served as the legal counsel, while McDermott Will & Emery LLP served as legal counsel to RC Capital. The financial terms of the deal were not disclosed. James River Cardiology operates out of six locations in the Richmond, Virginia MSA. According to its website, the practice is run by a team of eight physicians and a support staff of nine nurses and physician assistants. Founded in 1994, RC Capital... Read More »
Latticework Capital Management Partners with The Aesthetic Center for Plastic Surgery and ACPS the SurgiCentre
Latticework Capital Management announced on May 26 that it acquired The Aesthetic Center for Plastic Surgery, LLP and ACPS the SurgiCentre PA. Cross Keys Capital acted as the exclusive financial advisor to The Aesthetic Center for Plastic Surgery, LLP and ACPS the SurgiCentre PA. The financial terms were not disclosed. The Aesthetic Center for Plastic Surgery, LLP and ACPS the SurgiCentre PA is a multi-site cosmetic surgery practice and MedSpa. The two practices, which are partnered and work in tandem, provide services that include breast augmentation, body sculpting, liposuction, facial rejuvenation, laser procedures and other procedures. Latticework Capital Management makes control... Read More »
MedGenome Acquires Prognosis Laboratories
MedGenome Labs Ltd. announced on May 29 that it acquired Prognosis Laboratories for an undisclosed price. Wodehouse Capital was the exclusive financial advisor to Prognosis Laboratories. Wodehouse Capital was assisted by Khaitan & Co. as legal advisors to the undisclosed sellers. Prognosis Laboratories is a private diagnostic center in India that has been granted permission to conduct COVID-19 tests. It also provides cardiology, radio diagnosis, pathology, infertility, ultrasonography, ECG, hematology and digital X-ray services. It was founded in 2013 and is based in Dwarka, New Delhi. MedGenome Labs is a leading genetic diagnostics and research and data company based in India,... Read More »
Devices to Digital: Insights into the Medical Devices and eHealth Markets in Q1:23
The Medical Devices Market: As of May 26, 2023, a total of 46 Medical Device deals have been announced this year, and 28 of those deals were announced during Q1:23. The Q1:23 deal total is comparable to the 27 deals announced during Q1:22, yet an 18% drop from the 56 deals announced between January 1, 2022, and May 26, 2022. M&A activity is also 25% down compared to the 35 Medical Device deals announced during Q1:21, and 6% lower than the 49 deals announced between January 1, 2021, and May 26, 2021. While M&A is down compared to recent Q1’s, considering we just had a few years of unprecedented upheaval, the market is still at a better place than it was before the COVID-19 pandemic.... Read More »
The Physician Medical Groups Market Thrives, Despite Economic Instability
During the first five months of 2023, the Physician Medical Groups (PMG) sector has seen a large amount of M&A activity. There have been 244 PMG transactions reported, so far, which represents a 6% increase from the first five months of 2022. Considering the economic uncertainty currently plaguing investors, this increase is almost surprising. Yet, it was not surprising that the most active specialty was dental, with 80 transactions. Compared to the first five months of 2023, when 63 dental transactions were reported, this year’s 80 transactions is even more impressive. The most active acquirer, in the dental and PMG spaces overall, is MB2 Dental Solutions, a portfolio company of... Read More »
Medtronic Acquires Wearable Insulin Patch Maker EOFlow
Medtronic plc announced on May 25 that it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd. According to data captured in the LevinPro HC database, this represents the 46th Medical Devices transaction of the year. To the extent that all the public shares participate in the tender offer, the total consideration for the acquisition of the shares in EOFlow would be KRW 971 billion, or $738 million USD. EOFlow is a South Korean medical device company founded in 2011 and is headquartered in Seongnam, South Korea, with additional offices in San Jose, California. EOFlow’s flagship product is the EOPatch® device, a wearable insulin patch pump that provides continuous... Read More »
TA Associates Announces Strategic Growth Investment in Alpha II
TA Associates, a Boston-based private equity firm, announced that it has signed a definitive agreement to make a significant growth investment in Alpha II. As part of the transaction, Alpha II’s existing shareholder WestView Capital Partners will reinvest alongside TA Associates to maintain a minority position in the company. Alpha II is a provider of revenue cycle management (RCM) technology solutions to healthcare providers across the care continuum. TA Associates has invested in more than 560 companies around the world and raised more than $48.6 billion in capital since its founding in 1968. It leads buyouts and minority recapitalizations in the technology, financial services,... Read More »
Pyxis Oncology Acquires Apexigen
Pyxis Oncology announced on May 24 that it acquired Apexigen, Inc. for $16 million. Founded in 2010, Apexigen, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology. Pyxis Oncology is building a differentiated portfolio of biologics, including antibody-drug conjugates and immunotherapies. It is funded by the Longwood Fund, a Boston-based venture capital firm. This acquisition was announced nearly a year after Apexigen went public by a merger with Brookline Capital Acquisition Corp. According to data captured in the LevinPro HC database, this acquisition represents the 61st... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
